For patients with somatotroph PitNETs, various prognostic factors have been suggested, including a younger age and higher GH values at diagnosis, tumour hyperintensity signal in T2-weighted magnetic resonance imaging, somatostatin receptor expression, higher Ki-67 expression and the tumour cytokeratin pattern [5–8]. This evidence concerns the gene MKI67 and neoplasm.